Worth reading
40Recurring
Scored from 5 of 6 sectionsDirection
Mixed performance
Direction inferred from the company’s description.Scale
34.9
Year-on-year change in operating profit (%)Wording
Conditional
How definitive the wording is.Results for this period
Interim period (second quarter)2022年5月1日〜2022年10月31日ConsolidatedJapanese GAAPNet Sales24,396¥ millionYear on year +6.4%Progress 49.5%
Operating profit700¥ millionYear on year -34.9%Progress 33.7%
Ordinary income729¥ millionYear on year -33.3%Progress 34.5%
Net income attributable to owners of the parent457¥ millionYear on year -37.2%Progress 32.6%
The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
Net income per share17.21円
Financial position at period-end
Total assets35,603¥ million
of which net assets 28,751 ¥ millionEquity ratio 80.8%vs. prior year-end +1.1pt
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Cash inflows and outflows
Operating+858
Investment-589
Financials-1,204
Net change-935
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Cash and cash equivalents at end of period¥13,191 million
Outlook and shareholder returns
Full-year earnings forecast
Net Sales¥49,257 million (YoY +4.5%)
Operating profit¥2,080 million (YoY -3.5%)
Ordinary income¥2,116 million (YoY -3.2%)
Net income¥1,403 million (YoY +1.7%)
Annual Dividend Forecast¥40 per share → ¥22 per share（-45.0%）
Factors Behind Changes in Business Performance
新型コロナワクチン接種率の向上、「withコロナ」の生活様式への移行に伴う人流の回復。原材料価格やエネルギー価格の上昇、円安進行。新規出店および公式アプリの開設。
Disclosure regarding the going concern assumption
No applicable matters ("There are no applicable matters")
Change in accounting policy
基準改正に伴う変更 Noそれ以外の変更 No見積りの変更 No修正再表示 No
Changes in the scope of consolidation0 additions (company name: —), 0 exclusions (company name: —)
Depreciation and amortization¥819 million
Availability of Supplementary Financial Results MaterialsYes
Availability of Financial Results BriefingAvailable (for institutional investors and analysts)
Issued Shares at Period-End26,788,748
Treasury Shares at Period-End190,901
| Item | Details |
|---|---|
| Fiscal Period Classification | Interim period (second quarter) |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 2022年5月1日〜2022年10月31日 |
| Net Sales | ¥24,396 million (YoY +6.4%) |
| Operating profit | ¥700 million (YoY -34.9%) |
| Ordinary income | ¥729 million (YoY -33.3%) |
| Profit attributable to owners of the parent | ¥457 million (YoY -37.2%) |
| Net income per share | 17.21円 |
| Equity ratio | End of the current fiscal period 80.8% / End of previous period 79.7% |
| Total assets | ¥35,603 million |
| Net assets | ¥28,751 million |
| Cash flows from operating activities | ¥858 million |
| Cash flows from investing activities | ¥-589 million |
| Cash flows from financing activities | ¥-1,204 million |
| Cash and cash equivalents at end of period | ¥13,191 million |
| Full-year earnings forecast | Net Sales ¥49,257 million (YoY +4.5%) / Operating profit ¥2,080 million (YoY -3.5%) / Ordinary income ¥2,116 million (YoY -3.2%) / Net income ¥1,403 million (YoY +1.7%) |
| Annual Dividend Forecast | ¥40 per share → ¥22 per share（-45.0%） |
| Depreciation and amortization | ¥819 million |
| Disclosure regarding the going concern assumption | No applicable matters ("There are no applicable matters") |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | 0 additions (company name: —), 0 exclusions (company name: —) |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Available (for institutional investors and analysts) |
| Issued Shares at Period-End | 26,788,748 |
| Treasury Shares at Period-End | 190,901 |
| Factors Behind Changes in Business Performance | 新型コロナワクチン接種率の向上、「withコロナ」の生活様式への移行に伴う人流の回復。原材料価格やエネルギー価格の上昇、円安進行。新規出店および公式アプリの開設。 |
Items this document does not state (11)
Operating MarginRevision to Earnings ForecastPayout ratioShareholder Return PolicySegment revenueSegment profitRegional salesOrders received and order backlogImpairment lossBreakdown of extraordinary income (loss)Material subsequent events
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.新型コロナワクチン接種率の向上や「withコロナ」への移行に伴う人流回復があった一方、原材料価格・エネルギー価格の上昇や円安進行などがありました。会社は新規出店や公式アプリの開設にも取り組みました。
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.